Video yükleniyor...

Video Yüklenemedi

Ana Sayfaya Dön

ImmunityBio confirmed statistical power in our pivotal randomized trial evaluating ANKTIVA® + BCG versus BCG alone in BCG-naïve NMIBC, supporting the ability to detect clinically meaningful differences between treatment arms. This milestone builds on prior interim findings showing improved durability of complete response with ANKTIVA + BCG, reinforcing continued...

ImmunityBio's profile picture

ImmunityBio, Inc.

19,809 subscribers

11,424 görüntüleme • 3 ay önce •via X (Twitter)

LIVE

Anya Rossi• Live Now

Private livecam show

0 Yorum

Yorum bulunmuyor

Orijinal gönderinin yorumları burada görünecek

Benzer Videolar

We are pleased to announce positive topline event-free survival results from our Phase 3 study in patients with BCG-naïve, high-risk non-muscle invasive #BladderCancer (NMIBC). Learn more:
0:14

We are pleased to announce positive topline event-free survival results from our Phase 3 study in patients with BCG-naïve, high-risk non-muscle invasive #BladderCancer (NMIBC). Learn more:

Pfizer Inc.

11,655 görüntüleme • 1 yıl önce

Today, the Saudi Food and Drug Authority (SFDA) granted accelerated approval of ANKTIVA® for use in combination with immune checkpoint inhibitors for adult patients with metastatic NSCLC whose disease has progressed following standard-of-care therapy. This marks the first approval anywhere in the world for ANKTIVA in this indication. Learn more:
0:14

Today, the Saudi Food and Drug Authority (SFDA) granted accelerated approval of ANKTIVA® for use in combination with immune checkpoint inhibitors for adult patients with metastatic NSCLC whose disease has progressed following standard-of-care therapy. This marks the first approval anywhere in the world for ANKTIVA in this indication. Learn more:

ImmunityBio, Inc.

14,278 görüntüleme • 5 ay önce

ImmunityBio reported that median overall survival has not yet been reached in patients with recurrent or progressive glioblastoma treated with a chemo-free ANKTIVA® + CAR-NK-based regimen. As recent American Cancer Society data shows that brain cancer is now the third leading cause of cancer-related death among adults ages 20–49, these findings underscore the urgency of continued innovation in this disease. Read more:
0:14

ImmunityBio reported that median overall survival has not yet been reached in patients with recurrent or progressive glioblastoma treated with a chemo-free ANKTIVA® + CAR-NK-based regimen. As recent American Cancer Society data shows that brain cancer is now the third leading cause of cancer-related death among adults ages 20–49, these findings underscore the urgency of continued innovation in this disease. Read more:

ImmunityBio, Inc.

107,673 görüntüleme • 5 ay önce

We’ve reported ~700% year-over-year revenue growth, expanded ANKTIVA® authorizations in 33 countries, and continued progress in lung cancer. With additional label expansion plans and global commercialization efforts underway, we remain focused on broadening patient access worldwide. Read more:
0:14

We’ve reported ~700% year-over-year revenue growth, expanded ANKTIVA® authorizations in 33 countries, and continued progress in lung cancer. With additional label expansion plans and global commercialization efforts underway, we remain focused on broadening patient access worldwide. Read more:

ImmunityBio, Inc.

57,839 görüntüleme • 4 ay önce

A Mayo Clinic-developed artificial intelligence (AI) model can help specialists detect pancreatic cancer on routine abdominal CT scans up to three years before clinical diagnosis. It identifies subtle signs of disease before tumors are visible, when curative treatment may still be possible. The findings, published in Gut, mark a milestone in Mayo Clinic's multiyear research effort to enable earlier detection of one of the deadliest cancers. Learn more:
0:12

A Mayo Clinic-developed artificial intelligence (AI) model can help specialists detect pancreatic cancer on routine abdominal CT scans up to three years before clinical diagnosis. It identifies subtle signs of disease before tumors are visible, when curative treatment may still be possible. The findings, published in Gut, mark a milestone in Mayo Clinic's multiyear research effort to enable earlier detection of one of the deadliest cancers. Learn more:

Mayo Clinic

2,131,094 görüntüleme • 2 ay önce

At ImmunityBio, our pipeline continues to expand with chemotherapy-free approaches designed to harness the power of one's own immune system. We have launched ResQ215B, a Phase 2 clinical study evaluating a novel chemotherapy-free and lymphodepletion-free combination immunotherapy in patients with indolent B-cell non-Hodgkin lymphoma (iNHL), including Waldenström’s Macroglobulinemia. Learn more:
0:14

At ImmunityBio, our pipeline continues to expand with chemotherapy-free approaches designed to harness the power of one's own immune system. We have launched ResQ215B, a Phase 2 clinical study evaluating a novel chemotherapy-free and lymphodepletion-free combination immunotherapy in patients with indolent B-cell non-Hodgkin lymphoma (iNHL), including Waldenström’s Macroglobulinemia. Learn more:

ImmunityBio, Inc.

62,193 görüntüleme • 4 ay önce

In 2023 we recycled 938.8 million kg of waste globally instead of sending it to landfill. Learn more about our continued efforts on The #RoadToBetter.
0:14

In 2023 we recycled 938.8 million kg of waste globally instead of sending it to landfill. Learn more about our continued efforts on The #RoadToBetter.

Ford Motor Company

19,317 görüntüleme • 2 yıl önce

Additional video has emerged from the Shatura Power Plant attack. Since earlier footage of the strike and resulting fire was recorded in the dark, this appears to have been a continued attack. Despite attempts to stop the drone with small arms, it successfully reached its target
0:12

Additional video has emerged from the Shatura Power Plant attack. Since earlier footage of the strike and resulting fire was recorded in the dark, this appears to have been a continued attack. Despite attempts to stop the drone with small arms, it successfully reached its target

Tatarigami_UA

184,662 görüntüleme • 7 ay önce

We’re excited to announce the upcoming launch of our $UOMI Public Sale, a significant milestone in our mission to bring true AI Agents on-chain and expand our community. 🚀 As part of this journey, we’re thrilled to reveal Poolz Finance as one of the first launchpad partners supporting the Public Sale! This partnership represents a pivotal step in making our vision accessible to a broader audience. Stay tuned for more updates as we unveil additional launchpads and partners. The $UOMI Public Sale is coming soon.
0:12

We’re excited to announce the upcoming launch of our $UOMI Public Sale, a significant milestone in our mission to bring true AI Agents on-chain and expand our community. 🚀 As part of this journey, we’re thrilled to reveal Poolz Finance as one of the first launchpad partners supporting the Public Sale! This partnership represents a pivotal step in making our vision accessible to a broader audience. Stay tuned for more updates as we unveil additional launchpads and partners. The $UOMI Public Sale is coming soon.

Uomi

24,674 görüntüleme • 1 yıl önce

.Orion Spacecraft for #ArtemisII is complete! This milestone brings us closer to sending astronauts on a 10-day journey around the Moon! This milestone is a testament to our partnership with NASA and our shared vision for a sustainable presence in space.
0:14

.Orion Spacecraft for #ArtemisII is complete! This milestone brings us closer to sending astronauts on a 10-day journey around the Moon! This milestone is a testament to our partnership with NASA and our shared vision for a sustainable presence in space.

Lockheed Martin

20,902 görüntüleme • 1 yıl önce

#Announcement 📣: Our tissue-informed circulating tumor DNA monitoring test is now available to all physicians in the US seeking personalized monitoring of their patients' response to treatment. More on this #Launch news:
0:14

#Announcement 📣: Our tissue-informed circulating tumor DNA monitoring test is now available to all physicians in the US seeking personalized monitoring of their patients' response to treatment. More on this #Launch news:

Foundation Medicine

678,407 görüntüleme • 2 yıl önce

With World Health Organization (WHO)'s support, Ministry of Health- Uganda has started a vaccine trial against #Ebola Sudan virus today. The trial will enroll contacts of people with the disease, and contacts of the contacts. This vaccination trial was initiated with record speed, only three days since the outbreak was declared, while ensuring full compliance with international and national regulatory and ethical requirements. It is also the first trial to assess the clinical efficacy of a vaccine against Ebola Sudan virus disease. This trial demonstrates the importance of investing in R&D for vaccines and treatments and outbreak response preparedness, as well as partnerships. We thank Makerere University University and UVRI for their leadership, as well as Africa CDC, CEPI, EU HERA and IDRC | CRDI for their collaboration on this lifesaving effort. WHO will continue supporting the government in a comprehensive response to bring the outbreak under control.
0:19

With World Health Organization (WHO)'s support, Ministry of Health- Uganda has started a vaccine trial against #Ebola Sudan virus today. The trial will enroll contacts of people with the disease, and contacts of the contacts. This vaccination trial was initiated with record speed, only three days since the outbreak was declared, while ensuring full compliance with international and national regulatory and ethical requirements. It is also the first trial to assess the clinical efficacy of a vaccine against Ebola Sudan virus disease. This trial demonstrates the importance of investing in R&D for vaccines and treatments and outbreak response preparedness, as well as partnerships. We thank Makerere University University and UVRI for their leadership, as well as Africa CDC, CEPI, EU HERA and IDRC | CRDI for their collaboration on this lifesaving effort. WHO will continue supporting the government in a comprehensive response to bring the outbreak under control.

Tedros Adhanom Ghebreyesus

63,360 görüntüleme • 1 yıl önce

🏀 Learn how to dominate the court with three of the best MyPlayer Builds in NBA 2K23. Our latest GG Guide breaks it down:
0:10

🏀 Learn how to dominate the court with three of the best MyPlayer Builds in NBA 2K23. Our latest GG Guide breaks it down:

PlayStation

871,390 görüntüleme • 3 yıl önce

Chiarot, Seider have some words with Eriksson Ek in response to this hit on Kane earlier on. #LGRW
0:13

Chiarot, Seider have some words with Eriksson Ek in response to this hit on Kane earlier on. #LGRW

Ryan Hana

54,663 görüntüleme • 5 ay önce

We are pleased to announce that #FDA has cleared our IND application for PM359 for the treatment of chronic granulomatous disease (CGD), enabling Prime to initiate its Phase 1/2 clinical trial in the US. Details: $PRME
0:12

We are pleased to announce that #FDA has cleared our IND application for PM359 for the treatment of chronic granulomatous disease (CGD), enabling Prime to initiate its Phase 1/2 clinical trial in the US. Details: $PRME

Prime Medicine

140,780 görüntüleme • 2 yıl önce

Separation confirmed! ✅ The SpaceX rocket has demonstrated its ability to withstand the extreme conditions of launch. Our next big milestone will be to acquire #MissionToPsyche's signal and confirm the spacecraft is in good health, which could take up to 2 hours.
0:16

Separation confirmed! ✅ The SpaceX rocket has demonstrated its ability to withstand the extreme conditions of launch. Our next big milestone will be to acquire #MissionToPsyche's signal and confirm the spacecraft is in good health, which could take up to 2 hours.

NASA JPL

5,888,417 görüntüleme • 2 yıl önce

Peripheral artery disease is seen in 30% of people with diabetes over the age of 50.1 Learn more during ACC Congress 👇
0:20

Peripheral artery disease is seen in 30% of people with diabetes over the age of 50.1 Learn more during ACC Congress 👇

Novo Nordisk Live

4,953,852 görüntüleme • 1 ay önce

#NEWMCI – 70’ The referee’s call of goal was checked and confirmed by VAR – with both Guimarães and Barnes in onside positions in the build-up. The VAR also checked and confirmed the referee's call of no foul on Donnarumma prior to the goal.
0:07

#NEWMCI – 70’ The referee’s call of goal was checked and confirmed by VAR – with both Guimarães and Barnes in onside positions in the build-up. The VAR also checked and confirmed the referee's call of no foul on Donnarumma prior to the goal.

Premier League Match Centre

1,076,564 görüntüleme • 7 ay önce

NEW PRODUCT🚨 Meet the new Xperia 1 V – raising the bar for on-the-go content creators. With a newly developed image sensor, improved vlogging tools, best in class gaming performance, and longer lasting battery power with powerful CPU. Click to learn more
0:13

NEW PRODUCT🚨 Meet the new Xperia 1 V – raising the bar for on-the-go content creators. With a newly developed image sensor, improved vlogging tools, best in class gaming performance, and longer lasting battery power with powerful CPU. Click to learn more

Sony | Xperia US

20,240 görüntüleme • 3 yıl önce

Earlier this week I bid farewell to my tank collection, I’m grateful to help our friends in Ukraine stay safe. I hope for ever more support and swift success for our brave Ukrainian brothers & sisters in arms - for the sake of the civilised world... Oleksii Reznikov @BWallaceMP
0:05

Earlier this week I bid farewell to my tank collection, I’m grateful to help our friends in Ukraine stay safe. I hope for ever more support and swift success for our brave Ukrainian brothers & sisters in arms - for the sake of the civilised world... Oleksii Reznikov @BWallaceMP

Mark Gerhard

101,076 görüntüleme • 3 yıl önce